If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI boom—where would the technology ... company pioneering AI-driven drug ...

It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and Min-Wen Chung, COO, were working on the development of a novel bioimaging technology for drug screening and ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...